Martin Prinz

This inventor holds 9 USPTO granted patents and 1 published patent application and 5 EPO patents. Top assignees: Croma-Pharma Gesellschaft M.b.h., Croma Pharma Gmbh, Croma-Pharma Gesellchaft M.b.h.. Active years: 2006-2025.

USPTO Granted Patents = 9 (Patent Applications = 1)

% Patents Active = 66.7

EPO Patents = 5 (Patent Applications = 7)

Average Co-Inventor Count = 1.4

ph-index = 2

Forward Citations = 48(Granted Patents)

Location History:

Klosterneuburg, AT (2019 - 2020)
Leobendorf, AT (2006 - 2022)

Company Filing History:

4 out of 5

Croma-Pharma Gesellschaft M.b.h.

Croma-Pharma Gesellchaft M.b.h.

patent

4. 1 out of 1

Mucobiomer Biotechnologische Forschungs- Und Entwicklungs Gesmbh

patent

where one patent can have more than one assignee

Years Active: 2006-2025

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12297346 - Hydrogel composition comprising a crosslinked polymer (2025-05-13),

2. 12097277 - Hydrogel composition comprising a crosslinked polymer (2024-09-24),

3. 11331338 - Hydrogen sulfide releasing polymer compounds (2022-05-17),

4. 10813943 - Therapeutic use of a sterile aqueous ophthalmic solution (2020-10-27),

5. 10653620 - Method for treating dry eye syndrome (2020-05-19),

6. 10583152 - Therapeutic use of a sterile aqueous ophthalmic solution (2020-03-10),

7. D854148 - Handle for a cannula (2019-07-16),

8. 10342759 - Aqueous ophthalmic solution and method for treating dry eye syndrome (2019-07-09),

9. 7053068 - Chitosan-thio-amidine conjugates and their cosmetic as well as pharmaceutic use (2006-05-30),

Title: Martin Prinz: Innovator in Polymer Compounds and Ophthalmic Solutions

Introduction

Martin Prinz is a notable inventor based in Leobendorf, Austria. He has made significant contributions to the field of polymer compounds and ophthalmic solutions, holding a total of six patents. His work focuses on innovative solutions for medical applications, particularly in treating various health conditions.

Latest Patents

One of Martin Prinz's latest patents is for hydrogen sulfide releasing polymer compounds. This invention provides a polymer compound with a polysaccharide backbone that contains at least two substructures capable of releasing hydrogen sulfide through thiol activation. The applications of this invention include methods for treating and preventing skin conditions, ocular diseases, and osteoarthritis. Another significant patent involves a sterile aqueous ophthalmic solution that comprises N-(N-acetylcysteinyl-)chitosan or a pharmaceutically acceptable salt in a carrier solution. This solution is specifically designed for the prevention or treatment of dry eye syndrome and is intended to be applied before sleep.

Career Highlights

Throughout his career, Martin Prinz has worked with several companies, including Croma-Pharma Gesellschaft M.b.H. and Mucobiomer Biotechnologische Forschungs- und Entwicklungs GesmbH. His experience in these organizations has contributed to his expertise in developing innovative medical solutions.

Collaborations

Martin Prinz has collaborated with notable professionals in his field, including Martin Hoffer and Sonja Höller. These collaborations have further enhanced his research and development efforts.

Conclusion

Martin Prinz is a distinguished inventor whose work in polymer compounds and ophthalmic solutions has the potential to significantly impact medical treatments. His innovative patents reflect his commitment to advancing healthcare solutions.